American Society of Clinical Oncology
0
GSK's new drug, Blenrep, significantly reduces the risk of death or disease progression for multiple myeloma patients compared to standard treatments, ...
GSK's new drug, Blenrep, significantly reduces the risk of death or disease progression for multiple myeloma patients compared to standard treatments, ...